As of 2025-07-17, the Fair Value of Adamis Pharmaceuticals Corp (ADMP) is -69.93 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.78 USD, the upside of Adamis Pharmaceuticals Corp is -9,122.65%.
With the market price of 0.78 USD and our fair value calculation, Adamis Pharmaceuticals Corp (ADMP) is not a good investment. Investing in ADMP stocks now will result in a potential loss of 9,122.65%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | - | - | 5Y Avg | |
| Net income | -45.83 | -26.48 | - | - | -36.15 | |
| YoY growth | 7.21% | 42.22% | - | - | 24.72% | |
| Market Cap (mil) | 7.25 |
| P/E | |
| Forward P/E |
| EPS | -2.83 |
| Avg earnings growth rate | 24.72% |
| TTM earnings | -26.48 |